Source recordFED

ANDERSON, David R

Federal grants & contributions· Canadian Institutes of Health Research· FY2013· $3,044,877· NS

Description

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty (EPCAT II)

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$3,044,877$0Original · 2012-10-01 (start date) · total $3,044,877
  • #02012-10-01$3,044,877
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2012-10-01(start date)$3,044,877—Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arth…

Cite as: Glassbox record view · Federal grants & contributions · 236-2012-2013-Q2-00437 · retrieved 2026-11-13.